CYP1A1 and breast cancer: There were no significant differences in the mRNA levels of Cyp1a1 in both breast cancer cell lines (Fig 2F), but the protein levels of Cyp1a1 in Flavipin-treated cells were lower than TCDD (Fig 2F and 2G).